Wordt geladen...
Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705)
BACKGROUND: Severe fever and thrombocytopenia syndrome (SFTS) is an acute illness with a high mortality (16.2–29.1%). Unfortunately, there is no specific cure or vaccine for SFTS. METHODS: In this open-label study, two patients with SFTS were treated with favipiravir, a new antiviral drug. RESULTS:...
Bewaard in:
| Gepubliceerd in: | Infection |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Berlin Heidelberg
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7223615/ https://ncbi.nlm.nih.gov/pubmed/31673977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s15010-019-01364-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|